Neurotransmitter Systems and Drug Development

Embark on a journey through the intricate landscape of neurotransmitter systems and drug development at our session on Neurotransmitter Systems and Drug Development. Uncover the latest research on dopamine, serotonin, glutamate, and GABAergic pathways, and explore the potential of targeting these systems for the treatment of neurological and psychiatric disorders. From preclinical studies to clinical trials, this session will showcase innovative approaches to drug discovery and development, offering valuable insights into novel drug targets and therapeutic strategies. Join us for an enriching experience filled with engaging presentations, thought-provoking discussions, and networking opportunities with leaders in the field.

Track 1: Dopaminergic Modulation in Neurological Disorders
Track 2: Serotonergic Pathways and Psychiatric Pharmacology
Track 3: Glutamatergic Neuropharmacology in Addiction
Track 4: GABAergic Regulation in Anxiety and Sleep Disorders

    Related Conference of Neurotransmitter Systems and Drug Development

    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    April 27-28, 2026

    11th World Kidney Congress

    London, UK
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Neurotransmitter Systems and Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in